Def-LIV™ are a highly homogeneous population of hIPSC derived hepatocytes generated using completely defined and standardised conditions. The cells are utilized in convenient 12, 24 and 96 well plate formats for toxicology and lead optimization studies
DefiniGEN provides human liver cells for preclinical drug development and disease modelling applications using human Induced Pluripotent Stem Cell hIPSC technology.
Telephone: +44 (0)1223 497 113
Maia Building Babraham Research Campus Babraham
Post Code: CB22 3AT
Country: United Kingdom
Membership Type: Corporate 6-20